Bionorica SE
Records under this name other than the patents Bionorica SE holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,337,908 | Plant Extract from Low-Thc Cannabis for the Treatment of Disease Lapsed on the fee record Ended Dec 25, 2024 · High confidence | Lapsed on the fee record | Ended Dec 25, 2024 | High confidence |
| US 8,324,408 | Method for the preparation of dronabinol Formerly held Lapsed on the fee record Ended Dec 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2024 | From the USPTO record |
| US 10,603,344 | Plant Extract from Low-Thc Cannabis for the Treatment of Disease Lapsed on the fee record Ended Mar 31, 2024 · High confidence | Lapsed on the fee record | Ended Mar 31, 2024 | High confidence |
| US 6,996,919 | Process for obtaining dry extracts under mild conditions Term ended Term ended Aug 10, 2022 · From the USPTO record | Term ended | Term ended Aug 10, 2022 | From the USPTO record |
| US 7,291,250 | Vacuum distillation system and use thereof for concentrating organic-aqueous solvent mixtures Term ended Term ended Oct 20, 2019 · From the USPTO record | Term ended | Term ended Oct 20, 2019 | From the USPTO record |
| US 7,244,902 | Method for classifying wine and coffee Lapsed on the fee record Ended Jul 17, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2019 | From the USPTO record |
| US 8,734,857 | Hydrolysates made of plant extracts and antibacterial agent containing the same Lapsed on the fee record Ended May 27, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 27, 2018 | From the USPTO record |
| US 7,715,002 | Method for classifying scientific materials such as silicate materials, polymer materials and/or nanomaterials Lapsed on the fee record Ended May 11, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 11, 2018 | From the USPTO record |
| US 7,629,005 | Pharmaceutical formulation consisting of a plant dry extract with a calcium coating Lapsed on the fee record Ended Dec 8, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 8, 2017 | From the USPTO record |
| US 7,413,754 | Use of extracts of the genus Cimicifugaas organoselective medicines for treating diseases of the genitourinary system caused by sex hormones Lapsed on the fee record Ended Aug 19, 2016 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2016 | From the USPTO record |